Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Pharmacokinetics/
Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects with Androgenic Alopecia.